Nut Supplementation to Mitigate Post-stroke Cognitive Decline

Last updated: November 19, 2024
Sponsor: Monash University
Overall Status: Suspended

Phase

N/A

Condition

Stroke

Dementia

Memory Problems

Treatment

Nuts

Control

Clinical Study ID

NCT05902767
NUT-me
  • Ages 18-99
  • All Genders

Study Summary

Stroke is a strong risk factor for dementia, with up to 80% of individuals having lower cognitive function 5 years after a stroke event. However, having a stroke does not need to result in declining cognition if effective strategies to reduce the risk of post stroke dementia are identified. Diets containing nuts can reduce the risk of both dementia and stroke but have not been tested in stroke survivors. Therefore, this pilot study aims to determine whether eating nuts regularly reduces post-stroke cognitive decline and dementia. The NUT-me pilot study will supplement the diet of stroke survivors with a mix of nuts containing walnuts, hazelnuts, almonds and Brazil nuts for 3 months and assess the effects on cognition and health markers. The researchers predict that regular nut consumption will contribute to preserving post-stroke cognitive function in comparison to patients who do not consume nuts. The results of this novel pilot study will be used to guide a larger trial and provide a simple dietary strategy that stroke survivors can adopt to reduce post-stroke cognitive decline.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Ischaemic stroke (first or recurrent stroke) in the last 6 months

  • Able to attend 4 study visits over 3 months

  • Motivation and willingness to participate in the study protocol

  • No prior neurological or psychiatric disease, including dementia

  • Can give informed consent and participate in cognitive testing

Exclusion

Exclusion Criteria:

  • be < 18 years;

  • have allergy to nuts

  • have premorbid modified Rankin scale (mRS)≥4, denoting no severe disability

  • incapable of giving consent

  • have problems with mastication that preclude nut intake

  • have habitual consumption of tree nuts (>2 servings/wk) in the previous 2 months

  • have habitual consumption of alpha-linolenic acid supplements (fish oil, flaxseedoil, and/or soy lecithin)

  • have dementia or psychiatric disease

  • do not speak English

Study Design

Total Participants: 10
Treatment Group(s): 2
Primary Treatment: Nuts
Phase:
Study Start date:
June 30, 2023
Estimated Completion Date:
December 30, 2027

Study Description

This study will investigate the efficacy and feasibility of supplementing the habitual diet of stroke survivors with a supply of mixed nuts containing Brazil nut, walnuts, hazelnuts, and almonds to reduce post-stroke cognitive decline. The overall aim of this project will be achieved through the following objectives:

  • Examine the feasibility through the assessment of compliance with the intervention and participants' perception of the study

  • Investigate the efficacy of the intervention on cognitive decline, body composition and health outcomes (blood pressure, fasting glucose and insulin, and blood lipids) The investigators hypothesise that the inclusion of nuts is a simple dietary strategy that will slow post-stroke cognitive decline and that supplementation with nuts will improve body composition and health biomarkers of stroke survivors.

Connect with a study center

  • Department of Nutrition, Dietetics and Food - Monash University

    Melbourne, Victoria 3168
    Australia

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.